CA2574060A1 - Composes a modulation immunitaire issus de champignons - Google Patents

Composes a modulation immunitaire issus de champignons Download PDF

Info

Publication number
CA2574060A1
CA2574060A1 CA002574060A CA2574060A CA2574060A1 CA 2574060 A1 CA2574060 A1 CA 2574060A1 CA 002574060 A CA002574060 A CA 002574060A CA 2574060 A CA2574060 A CA 2574060A CA 2574060 A1 CA2574060 A1 CA 2574060A1
Authority
CA
Canada
Prior art keywords
composition
composition according
polysaccharides
glucose
mannose
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002574060A
Other languages
English (en)
Other versions
CA2574060C (fr
Inventor
Bjoern Kristiansen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glycanova As
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/892,393 external-priority patent/US7514085B2/en
Application filed by Individual filed Critical Individual
Publication of CA2574060A1 publication Critical patent/CA2574060A1/fr
Application granted granted Critical
Publication of CA2574060C publication Critical patent/CA2574060C/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00Preparation of compounds containing saccharide radicals
    • C12P19/04Polysaccharides, i.e. compounds containing more than five saccharide radicals attached to each other by glycosidic bonds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/39Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06Fungi, e.g. yeasts
    • A61K36/07Basidiomycota, e.g. Cryptococcus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06Fungi, e.g. yeasts
    • A61K36/07Basidiomycota, e.g. Cryptococcus
    • A61K36/074Ganoderma
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • A61P31/06Antibacterial agents for tuberculosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/16Antivirals for RNA viruses for influenza or rhinoviruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/20Antivirals for DNA viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/08Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis for Pneumocystis carinii
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00Preparation of peptides or proteins
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Wood Science & Technology (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pulmonology (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

L'invention se rapporte à des compositions contenant des polypeptides et des polysaccharides. Ces compositions sont généralement à modulation immunitaire. Cette invention se rapporte aussi à des procédés de fabrication de ces compositions au moyen de champignons filamenteux cultivés dans un milieu liquide. Ces compositions sont utiles par exemple dans le traitement de conditions de faiblesse immunitaire.
CA2574060A 2004-07-16 2005-07-15 Composes a modulation immunitaire issus de champignons Active CA2574060C (fr)

Applications Claiming Priority (15)

Application Number Priority Date Filing Date Title
US10/892,393 2004-07-16
US10/892,393 US7514085B2 (en) 2004-07-16 2004-07-16 Immune modulating compounds from fungi
US69048205P 2005-06-15 2005-06-15
US69049605P 2005-06-15 2005-06-15
US69047705P 2005-06-15 2005-06-15
US60/690,496 2005-06-15
DKPA200500881 2005-06-15
DKPA200500880 2005-06-15
DKPA200500881 2005-06-15
DKPA200500880 2005-06-15
US60/690,477 2005-06-15
DKPA200500882 2005-06-15
US60/690,482 2005-06-15
DKPA200500882 2005-06-15
PCT/DK2005/000498 WO2006007848A2 (fr) 2004-07-16 2005-07-15 Composes a modulation immunitaire issus de champignons

Publications (2)

Publication Number Publication Date
CA2574060A1 true CA2574060A1 (fr) 2006-01-26
CA2574060C CA2574060C (fr) 2019-06-25

Family

ID=35414957

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2574060A Active CA2574060C (fr) 2004-07-16 2005-07-15 Composes a modulation immunitaire issus de champignons

Country Status (8)

Country Link
EP (1) EP1774012A2 (fr)
JP (3) JP2008525311A (fr)
KR (1) KR20070057803A (fr)
AU (1) AU2005263329A1 (fr)
CA (1) CA2574060C (fr)
IL (1) IL180713A0 (fr)
TW (1) TW200607863A (fr)
WO (1) WO2006007848A2 (fr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO20014256D0 (no) 2001-09-03 2001-09-03 Bjoern Kristiansen Fremstilling av immunstimulerende forbindelse
WO2006133707A2 (fr) * 2005-06-15 2006-12-21 Medimush A/S Polytherapie contre le cancer et kit de composants associe
EP1896601A1 (fr) * 2005-06-15 2008-03-12 Medimush A/S Agents bio-actifs produits par culture immergee de cellule de basidiomycete
KR100825119B1 (ko) * 2006-12-29 2008-04-25 영남대학교 산학협력단 간질환의 예방 또는 치료용 약학조성물
WO2010130036A1 (fr) * 2009-05-15 2010-11-18 Her Majesty The Queen In Right Of The Province Of Nova Scotia, As Represented By The Nova Scotia Agricultural College (Nsac) On Behalf Of The Minister Of Agriculture Compositions de boissons fonctionnelles stables et leurs procédés de fabrication
KR101695488B1 (ko) * 2013-12-06 2017-01-23 한명순 설사 예방 및 개선용 조성물 및 이를 이용한 경구용 주사기 패키지
WO2015083982A1 (fr) * 2013-12-06 2015-06-11 한명순 Composition pour prévenir la diarrhée et améliorer son traitement et emballage de seringue orale l'utilisant
EP3244905A4 (fr) 2015-01-18 2018-12-12 Gavish-Galilee Bio Applications Ltd Extraits de champignons comestibles enrichis en vitamine d et compositions associées, et leur utilisation dans le traitement de troubles liés au système immunitaire
WO2017201615A1 (fr) * 2016-05-23 2017-11-30 Orphaderm Limited Compositions biophotoniques comprenant un chromophore d'origine fongique
KR20180093725A (ko) 2017-02-14 2018-08-22 강원대학교산학협력단 렌티난을 함유하는 패혈증의 치료 또는 개선용 약학적 조성물
CN108410944A (zh) * 2018-06-05 2018-08-17 郑州安图生物工程股份有限公司 一种检测艰难梭菌用培养基及其制备方法
TWI673058B (zh) * 2018-07-20 2019-10-01 金穎生物科技股份有限公司 靈芝複合多醣體組成物
CN110403962A (zh) * 2019-09-04 2019-11-05 湖南宇山玉月农业科技有限公司 一种真菌植物在防治鸡坏死性肠炎的应用
CN110656053B (zh) * 2019-11-01 2021-04-13 广东省微生物研究所(广东省微生物分析检测中心) 一种鳞伞属新菌种及其人工栽培方法和用途
FI130808B1 (fi) * 2021-02-19 2024-03-27 Natural Resources Inst Finland Luke Sieniperäinen koostumus, sen tuotantomenetelmä ja käytöt
IT202100029000A1 (it) 2021-11-16 2023-05-16 C I A M S R L Composizioni immunostimolanti per animali da compagnia

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1572074A (en) * 1977-03-30 1980-07-23 Kirin Seagram Ltd Chemotherapeutic substances and methods of manufacturing same
JPS54148702A (en) * 1978-05-12 1979-11-21 Kirin Brewery Kss22b
JPS5653101A (en) * 1979-09-21 1981-05-12 Kirin Brewery Co Ltd Polysaccharide ks-2-d and its preparation
JPH0757761B2 (ja) * 1984-03-08 1995-06-21 株式会社林原生物化学研究所 β−グルカンとその製造方法及び用途
EP0292601A1 (fr) * 1987-05-14 1988-11-30 Noda Shokukin Kogyo Co., Ltd. Médicaments contre le sida extrait de lentinus edodes
FR2631829B1 (fr) * 1988-05-30 1992-04-03 Pasteur Institut Exopolysaccharides fongiques ayant une activite immunostimulante, leur procede d'obtention et composition therapeutique les contenant
JPH0725802B2 (ja) * 1988-11-28 1995-03-22 味の素株式会社 カードランまたはレンチナンの硫酸エステルまたはその塩の製造方法
JP3522772B2 (ja) * 1991-05-21 2004-04-26 台糖株式会社 ワクチンの免疫効果増強剤
JP3651697B2 (ja) * 1995-03-24 2005-05-25 株式会社アミノアップ化学 新規多糖体物質
CN1069650C (zh) * 1995-12-29 2001-08-15 中国科学院上海药物研究所 香菇多糖的分离纯化方法
AU6261999A (en) * 1998-09-25 2000-04-17 Collaborative Group, Ltd., The Very high molecular weight beta-glucans
NO20014256D0 (no) * 2001-09-03 2001-09-03 Bjoern Kristiansen Fremstilling av immunstimulerende forbindelse
CA2538218C (fr) * 2003-09-08 2014-11-25 Genyous Biomed International Inc. Compositions d'extraits botaniques utilisees dans la therapie cancereuse

Also Published As

Publication number Publication date
AU2005263329A1 (en) 2006-01-26
JP2008525311A (ja) 2008-07-17
TW200607863A (en) 2006-03-01
WO2006007848A3 (fr) 2006-02-23
EP1774012A2 (fr) 2007-04-18
WO2006007848A2 (fr) 2006-01-26
IL180713A0 (en) 2007-06-03
JP5502830B2 (ja) 2014-05-28
JP2012017347A (ja) 2012-01-26
JP5926226B2 (ja) 2016-05-25
KR20070057803A (ko) 2007-06-07
JP2014005307A (ja) 2014-01-16
CA2574060C (fr) 2019-06-25

Similar Documents

Publication Publication Date Title
US7682615B2 (en) Immune modulating compounds from fungi
CA2574060C (fr) Composes a modulation immunitaire issus de champignons
US20100086647A1 (en) Feed or food products comprising fungal material
US20090005340A1 (en) Bioactive Agents Produced By Submerged Cultivation of a Basidiomycete Cell
JP2004514403A (ja) 高等担子菌類キノコからの栄養補助剤としてのグルクロンオキシロマンナンの製造方法及びその組成物
EP1854467B1 (fr) Composition immunostimulante
KR100945587B1 (ko) 동충하초 균사체로 발효시켜 다양한 생리활성을 갖는 진세노사이드 대사체를 다량 함유하는 발효인삼 또는 발효홍삼의 제조방법
JP5391282B2 (ja) 樺孔茸抽出物、霊芝抽出物及び桑黄抽出物を含有する造血幹細胞増殖促進用組成物
TW201021816A (en) Composition comprising a combination of an elder extract and a strain of L. paracasei, L. casei, L. bulgaricus or S. thermophilus
US11191793B2 (en) Ganoderma lucidum polysaccharides composite composition
JP2005220065A (ja) 免疫賦活剤
KR100340663B1 (ko) 이노노투스 오브리쿠우스의 인공배양물로부터 분리된 항암면역활성 다당류의 제조방법 및 그 용도
TW201919657A (zh) 提昇免疫之組合物及方法
CN100417391C (zh) 用于免疫活性或防治癌症的包含从酿酒酵母is2中得到的可溶性葡聚糖低聚物的组合物及其制备方法
KR20180042936A (ko) 치마버섯 분리 균사체 배양액을 유효성분으로 함유하는 숙취해소 및 간질환의 예방 및 치료용 약학조성물
JP2003040785A (ja) 感染抑制組成物及びそれを含有する飲食品
KR100589113B1 (ko) 대장암 원인 장내유해세균 효소 및 헬리코박터 파이로리성장 저해 활성을 갖는 버섯 유산균 발효물의 제조 및그의 용도
WO2006126488A1 (fr) Extrait de sparassis crepu
KR20200092951A (ko) I형 알레르기용 조성물
KR100593533B1 (ko) 펠리누스 질부스 균사체 추출물을 함유하는 면역 활성증강용 조성물
KR20210096552A (ko) 케피어 유래 유산균의 세포표면단백질을 포함하는 비만의 예방 또는 치료용 조성물
CN113018308A (zh) 用于调节免疫平衡的组合物

Legal Events

Date Code Title Description
EEER Examination request